|
Market Closed -
Hong Kong S.E.
08:08:08 03/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.4250 HKD | -1.16% |
|
-2.30% | -15.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.16% | -2.30% | -15.84% | +6.25% | -15.00% | -18.27% | -8.60% | -63.36% | - | 226M | |
| -2.37% | -5.03% | -17.14% | +7.96% | +52.97% | +39.49% | +62.39% | +5.22% | - | 62.23B | |
| +1.33% | +1.51% | -2.19% | +10.02% | +10.85% | +11.95% | +70.66% | +188.00% | +5,892.46% | 54.92B | |
| +0.46% | +2.20% | +13.05% | +15.99% | +20.83% | +20.51% | +97.45% | -15.35% | +261.00% | 55.26B | |
| +0.41% | -4.44% | -2.48% | +11.19% | +15.11% | +21.32% | +31.58% | +1.92% | +259.34% | 42.59B | |
| -1.71% | -3.29% | -2.11% | +12.82% | +16.52% | +13.52% | +92.63% | -5.27% | +1,031.75% | 41.08B | |
| +3.46% | +4.07% | -6.68% | +6.22% | +143.31% | +226.65% | +774.55% | +485.85% | - | 40.33B | |
| +0.35% | +23.86% | +56.16% | +101.08% | +83.13% | +99.09% | +83.76% | +25.62% | +212.20% | 33.12B | |
| +0.21% | +1.05% | +5.15% | +2.84% | +11.38% | +14.81% | +46.96% | +13.09% | +158.25% | 32.61B | |
| -1.84% | +13.34% | +3.66% | +9.32% | -38.16% | -42.21% | +333.10% | +231.97% | +938.85% | 23.98B | |
| -3.45% | -3.58% | -22.27% | +10.98% | +36.96% | +20.89% | -10.20% | -60.93% | - | 23.33B | |
| -0.70% | +0.85% | -10.08% | -4.82% | -7.77% | -15.54% | -8.33% | -70.28% | - | 21.99B | |
| +2.56% | -1.29% | +7.18% | +16.01% | +18.41% | +11.96% | +142.54% | +196.59% | +2,187.82% | 18.13B | |
| +4.08% | -2.34% | +12.76% | +51.79% | +75.67% | +95.93% | +92.64% | -9.64% | +419.93% | 16.16B | |
| -0.43% | +2.55% | +16.04% | +29.41% | +40.48% | +45.66% | +70.21% | -15.11% | +118.17% | 17.11B | |
| +2.85% | +9.92% | +22.06% | +30.47% | +63.89% | +88.74% | +242.07% | +273.36% | +604.26% | 17.11B | |
| +0.94% | +2.09% | +10.07% | +3.10% | - | - | - | - | - | 16.35B | |
| +1.89% | +13.51% | +23.39% | +31.12% | +13.98% | +23.05% | -19.53% | -24.64% | +170.87% | 15.37B | |
| 0.00% | +2.59% | +2.15% | +12.26% | +180.86% | +165.07% | +348.66% | +1,411.75% | +801.47% | 15.14B | |
| +2.91% | +11.64% | -3.59% | +74.92% | +36.41% | -9.20% | - | - | - | 14.29B | |
| Average | +0.48% | +3.24% | +4.46% | +21.95% | +39.99% | +42.81% | +135.70% | +142.71% | +1,004.34% | 28.07B | |
| Weighted average by Cap. | +0.27% | +2.61% | +3.45% | +19.48% | +40.11% | +45.02% | +142.86% | +116.72% | +1,306.18% |
- Stock Market
- Stocks
- 2181 Stock
- Sector Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
